Transnasal butorphanol is effective for postoperative pain relief in children undergoing myringotomy

R E Bennie1, L A Boehringer, S F Dierdorf

  • 1Department of Anesthesia, Indiana University School of Medicine, Indianapolis 46202-5200, USA. rbennie@iupui.edu

Anesthesiology
|August 26, 1998
PubMed

Insights

Transnasal butorphanol at 25 mcg/kg effectively managed pain after bilateral myringotomy and tube placement (BMT) in children. This route offers an alternative for postoperative pain relief when IV access is not feasible.

Area of Science:

  • Anesthesiology
  • Pediatric Pain Management
  • Pharmacology

Background:

  • Over 70% of children need pain relief after bilateral myringotomy and tube placement (BMT).
  • Anesthesia for BMT often uses face masks, precluding intravenous catheter use for analgesia.
  • Transnasal butorphanol is a potential alternative for postoperative pain management in pediatric patients.

Purpose of the Study:

  • To evaluate the effectiveness of transnasal butorphanol for managing postoperative pain in children undergoing BMT.
  • To determine the optimal dosage of transnasal butorphanol for pediatric pain relief post-BMT.

Main Methods:

  • A double-blinded, placebo-controlled study involving 60 pediatric patients (ASA physical status 1 or 2, aged ≥6 months) undergoing elective BMT.
  • Randomization to receive transnasal placebo or butorphanol at doses of 5, 15, or 25 mcg/kg after anesthesia induction.
  • Postoperative pain assessment using the Children's Hospital of Eastern Ontario Pain Scale (CHEOPS) at multiple time points.

Main Results:

  • The 25 mcg/kg transnasal butorphanol group showed significantly lower CHEOPS scores compared to the placebo group.
  • Significantly fewer children in the 25 mcg/kg group required rescue analgesia (1 vs. 8, P = 0.02).

Conclusions:

  • Transnasal butorphanol, administered at 25 mcg/kg post-anesthesia induction, provides effective postoperative pain relief for children undergoing BMT.
  • This non-intravenous route is a viable option for analgesia in pediatric BMT patients.
Abstract

Related Concept Videos

Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...